4//SEC Filing
MUELLER PETER 4
Accession 0001104659-19-047150
CIK 0001720893other
Filed
Aug 22, 8:00 PM ET
Accepted
Aug 23, 4:26 PM ET
Size
6.7 KB
Accession
0001104659-19-047150
Insider Transaction Report
Form 4
MUELLER PETER
Director
Transactions
- Purchase
Common Stock
2019-08-21$8.42/sh+1,800$15,156→ 160,120 total - Purchase
Common Stock
2019-08-22$8.83/sh+6,646$58,684→ 166,766 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. The shares were acquired in multiple transactions at prices ranging from $8.29 to $8.46, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in this footnote.
- [F2]The price reported in Column 4 is a weighted average price. The shares were acquired in multiple transactions at prices ranging from $8.43 to $9.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the SEC, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in this footnote.
Documents
Issuer
BioXcel Therapeutics, Inc.
CIK 0001720893
Entity typeother
Related Parties
1- filerCIK 0001256126
Filing Metadata
- Form type
- 4
- Filed
- Aug 22, 8:00 PM ET
- Accepted
- Aug 23, 4:26 PM ET
- Size
- 6.7 KB